![Jeffrey Friedman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Friedman
Director/Board Member at DTx Pharma, Inc.
Jeffrey Friedman active positions
Companies | Position | Start | End |
---|---|---|---|
DTx Pharma, Inc.
![]() DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Director/Board Member | 01/04/2018 | - |
Chief Operating Officer | 01/04/2018 | - |
Career history of Jeffrey Friedman
Former positions of Jeffrey Friedman
Companies | Position | Start | End |
---|---|---|---|
Celsense, Inc.
![]() Celsense, Inc. Medical DistributorsDistribution Services Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA. | Director/Board Member | - | - |
Statistics
International
United States | 3 |
Operational
Director/Board Member | 2 |
Chief Operating Officer | 1 |
Sectoral
Distribution Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Celsense, Inc.
![]() Celsense, Inc. Medical DistributorsDistribution Services Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA. | Distribution Services |
DTx Pharma, Inc.
![]() DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Friedman
- Experience